Adbelizumab Combined With Chemotherapy for Neoadjuvant Therapy in Resectable Pancreatic Cancer

Conditions: Pancreatic Cancer; Neoadjuvant Therapy Interventions: Drug: Adbelimumab; Drug: albumin-bound paclitaxel; Drug: Gemcitabine Sponsors: Jinling Hospital, China; Jiangsu Hengrui Pharmaceutical Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials